Pajevic, Paola Divieti

Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts

Kim, S. W., Pajevic, P. D., Selig, M., Barry, K. J., Yang, J.-Y., Shin, C. S., Baek, W.-Y., Kim, J.-E., & Kronenberg, H. M. (2012) · Journal of Bone and Mineral Research

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 266

Effects of PTH on osteocyte function

Bellido, T., Saini, V., & Pajevic, P. D. (2013) · Bone

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 196

Parathyroid Hormone (PTH)/PTH-related Peptide Type 1 Receptor (PPR) Signaling in Osteocytes Regulates Anabolic and Catabolic Skeletal Responses to PTH

Saini, V., Marengi, D. A., Barry, K. J., Fulzele, K. S., Heiden, E., Liu, X., Dedic, C., Maeda, A., Lotinun, S., Baron, R., et al. (2013) · Journal of Biological Chemistry

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 167

HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes

Wein, M. N., Spatz, J., Nishimori, S., Doench, J., Root, D., Babij, P., Nagano, K., Baron, R., Brooks, D., Bouxsein, M., et al. (2015) · Journal of Bone and Mineral Research

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 158

A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction

Sato, T., Verma, S., Andrade, C. D. C., Omeara, M., Campbell, N., Wang, J. S., Cetinbas, M., Lang, A., Ausk, B. J., Brooks, D. J., et al. (2020) · Nature Communications

Bone Metabolism and DiseasesCellular Mechanics and Interactions

Cited by 86

Osteocyte secreted factors inhibit skeletal muscle differentiation

Wood, C. L., Pajevic, P. D., & Gooi, J. H. (2017) · Bone Reports

Muscle Physiology and DisordersBone Metabolism and Diseases

Cited by 24

Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss

Uda, Y., Saini, V., Petty, C. A., Alshehri, M., Shi, C., Spatz, J. M., Santos, R., Newell, C. M., Huang, T. Y., Kochen, A., et al. (2021) · Aging

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 20

Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH

Yuan, Y., Jagga, S., Martins, J. S., Rana, R., Pajevic, P. D., & Liu, E. S. (2021) · PLOS ONE

Parathyroid Disorders and TreatmentsBone Metabolism and Diseases

Cited by 17